A newly released study of health risks from radon in Connecticut’s drinking water supplies concludes that such exposure poses a minimal threat to public health, primarily by increasing overall exposure slightly when radon in the water is released into...
Nine Yale School of Medicine researchers have been awarded research grants from the National Alliance for Research on Schizophrenia and Depression (NARSAD). Two of the Yale researchers – George R. Heninger, M.D., professor of psychiatry, and Robert H...
Long before the “Starr Report” and alleged presidential perjury were the topic of the day, Yale pediatric oncologist Dr. Diane Komp decided to explore the issue of lying: why people do it and whether lies are ever justified. Her just-published book...
Gail D’Eramo Melkus is fighting a vicious and subtle epidemic. Melkus, an associate professor at the Yale School of Nursing, studies diabetes in African-American women along with co-investigator Geralyn Spollett, assistant professor. Their work is...
Yale University has received a five-year, $4.3 million grant from The Robert Wood Johnson Foundation to pursue advanced research in public health and health care. The grant will support Yale’s continued participation in the Foundation’s Scholars in...
Researchers at Yale University School of Medicine and the Institutes for Pharmaceutical Discovery in Branford, Conn., have discovered a possible new mechanism for the body to control its fat stores by inducing the growth of new blood vessels, which...
Researchers at Yale University School of Medicine and the Institutes for Pharmaceutical Discovery in Branford, Conn., have discovered a possible new mechanism for the body to control its fat stores by inducing the growth of new blood vessels, which...
Yale University announced today that it has entered into a settlement agreement with the United States Attorney for Connecticut and the Department of Health and Human Services Office of Inspector General that ends an investigation of the handling of...
U.S. Sen. Daniel Patrick Moynihan, D-N.Y., and Alan I. Leshner, Ph.D., director of the National Institute on Drug Abuse, will be featured speakers Sept. 18-20 at a special historical conference marking the centennial of the commercial introduction of...
A drug that lowers brain levels of the chemical glutamate – one of the neurotransmitters responsible for relaying messages between neurons – can reverse symptoms of a rat model of schizophrenia without apparent side effects, according to a Yale...